The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side-effect resulting from numerous neurotoxic chemotherapies that damages the peripheral nerves, alters sensations in the hands and feet, causes burning and shooting pains, and impairs a patient’s quality of life (QoL). There are...

Full description

Bibliographic Details
Main Authors:	Sumedha Shastry, David Mizrahi, Grace Kanzawa-Lee
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Physiologia
Subjects:	cancer exercise: physical activity: rehabilitation neuropathy peripheral neuropathy chemotherapy-induced peripheral neuropathy taxane-induced peripheral neuropathy
Online Access:	https://www.mdpi.com/2673-9488/3/4/42

Similar Items

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
by: R. Dixon Dorand, et al.
Published: (2023-01-01)

Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023-04-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
by: Sardo S, et al.
Published: (2023-09-01)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
by: Junting Jia, et al.
Published: (2021-11-01)

Comparison of Clinical Symptoms and Neurophysiological Findings in Patients With Chemotherapy Induced Peripheral Neuropathy
by: Kye Hee Cho, et al.
Published: (2022-06-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
by: Jennifer M. Mongiovi, et al.
Published: (2018-11-01)

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-02-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
by: Lauren Schwab, et al.
Published: (2023-01-01)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
by: Pasquale Sansone, et al.
Published: (2022-08-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
by: Jingtong Zhai, et al.
Published: (2023-02-01)

Bortezomib-induced neurotoxicity in human neurons is the consequence of nicotinamide adenine dinucleotide depletion
by: Andrew R. Snavely, et al.
Published: (2022-12-01)

Prevalence and predictors of peripheral neuropathy after breast cancer treatment
by: Mandana Kamgar, et al.
Published: (2021-10-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Patricia Teran-Wodzinski, et al.
Published: (2022-04-01)

Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
by: Jae-Gyeong Jeong, et al.
Published: (2023-01-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
by: Jamie Burgess, et al.
Published: (2021-01-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)

Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-01-01)

A HOME-BASED EXERCISE PROGRAM TO IMPROVE NEUROMUSCULAR AND SPATIO-TEMPORAL GAIT PARAMETERS IN A MULTIPLE MYELOMA CANCER SURVIVOR WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A CASE REPORT
by: Timothy F. Marshall, et al.
Published: (2019-08-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment
by: Samvel Tonyan, et al.
Published: (2023-04-01)

The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
by: Karolina Łuczkowska, et al.
Published: (2021-10-01)

Corrigendum: Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-03-01)